Table 1.
Variable | N(%) or median (IQR)* | |
---|---|---|
Age (months) | 12 (4.5–27) | |
Sex | Male: 8(80%) | |
Female: 2(20%) | ||
Weight (Kg) | 8 (5.1–14) | |
Comorbidity | Previously healthy | 9 (90%) |
CHD | 1(10%) | |
Clinical presentations | Fever | 10 (100%) |
Respiratory | 4 (40%) | |
Gastrointestinal (vomiting ± diarrhoea) | 6(60%) | |
Mucocutaneous lesions | 7 (70%) | |
Shock | 1 (10%) | |
Others: | ||
Gangrene | 1 (10%) | |
Lymphadenopathy | 1 (10%) | |
Jaundice | 1 (10%) | |
Basic laboratory findings | CRP (mg/L) | 82.5(42.75–146.5) |
ESR (mm/h) | 78.2(19.5–127.5) | |
TLC (103/μL) | 14.2(11.2–22) | |
Lymphocytes (103/μL) | 2.45(1.93–5.25) | |
Hgb (g/L) | 7.65(6.98–8.75) | |
Platelet (103/μL) | 310(245–354) | |
Serum ferritin (ng/ml) | 371 (131.56–532.5) | |
COVID-19-related laboratory findings | PCR positive | 1(10%) |
COVID-19 antibodies (IgM and IgG) | 10(100%) |
Data are expressed as median (interquartile range) or frequencies (percentage).
CRP = C-reactive protein; ESR = Erythrocyte sedimentation rate; Hgb = hemoglobin; PCR = polymerase chain reaction; TLC = total leucocytic count.